Logo Logo
Help
Contact
Switch Language to German
Knop, S.; Langer, C.; Engelhardt, M.; Stübig, T.; Schreder, M.; Dechow, T.; Mügge, L.-O.; Bassermann, F.; Schäfer-Eckart, K.; Blau, I.-W.; Wolleschak, D.; Kropff, M.; Reichle, A.; Metzler, I. von; Metzner, B.; Röllig, C.; Hertenstein, B.; Pfreundschuh, M.; Dürk, H.; Biersack, H.; Ostermann, H.; Menzel, H.; Schleicher, J.; Gramatzki, M.; Gerecke, C.; Müller, M.; Brüggemann, M.; Held, S.; Einsele, H. (2017): Lenalidomide, adriamycin and dexamethasone (RAD) versus bortezomib, lenalidomide and dexamethasone (VRD) as induction regimens in newly diagnosed multiple myeloma - first results from the DSMM XIV study. In: Oncology Research and Treatment, Vol. 40: p. 36
Full text not available from 'Open Access LMU'.